NASDAQ
Clinuvel Pharmaceuticals Limited (CLVLF) has a interest coverage ratio of 10.25x as of Wednesday, July 15, 2026. This represents a 30.39% decrease compared to its 12-month average of 14.72x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.